Forget the trade war headlines. The real action is happening in server rooms across Shenzhen, Bangalore, and Tokyo, where a new breed of AI startups is rolling out models that match—and sometimes beat—the banned American originals. The U.S. tried to keep its most advanced AI inside its borders. Instead, it may have just created its own worst competitor.
The Export Ban That Backfired
When the Commerce Department slapped export restrictions on Anthropic's Mythos in late 2025, the stated goal was simple: keep cutting-edge AI out of adversary hands. But bans have a funny way of spurring innovation. Within weeks, Asian labs that had been quietly reverse-engineering Mythos's architecture began to surface with their own versions.
“We didn't need to steal anything,” a lead engineer at a Singapore-based AI firm told me. “The open-source papers and leaked benchmarks gave us 90% of what we needed. The ban just accelerated our timeline.”
Now, six months later, at least four Asian startups have launched models claiming “Mythos-like” capabilities in reasoning, code generation, and multimodal understanding. They market them aggressively to local enterprises, governments, and SMEs that would have been locked out of Mythos anyway.
Meet the Contenders
The most prominent is Shenzhen-based AetherMind, which dropped its LM-7 model in March. Independent benchmarks show it scoring within 3% of Mythos on the GPQA reasoning test. AetherMind's CEO, Li Wei, doesn't shy away from the comparison: “We built this for the Asian market. We understand the languages, the regulatory needs, the business culture. Mythos was a foreign product. Ours is homegrown.”
Then there's Bangalore's Vajra AI, which took a different route. Rather than clone Mythos wholesale, Vajra optimized its model for India's diverse language landscape—Hindi, Tamil, Bengali, and a dozen others. The result is a model that may not top every global leaderboard but crushes Mythos in real-world deployment across the subcontinent.
Tokyo's Kumo Labs and Seoul's Hanbit Intelligence round out the pack, each focusing on niche strengths: Kumo in robotics-related reasoning, Hanbit in financial modeling.
The Market That Got Away
Here's the number that should keep U.S. AI executives up at night: Asia-Pacific accounts for roughly 40% of global AI spending, and that share is growing. Before the ban, Anthropic had captured about 15% of that market. Now, with Mythos effectively blocked from direct sale in China, India, and parts of Southeast Asia, that slice is up for grabs.
American labs aren't completely locked out. Some customers use VPNs and third-party resellers to access Mythos. But it's a cat-and-mouse game that most enterprises don't want to play. “Why risk a compliance headache when a local model does the job?” asked a procurement manager at a Thai bank.
The irony is thick. The U.S. government's attempt to protect national security may have permanently ceded one of the world's fastest-growing AI markets to local competitors. And those competitors are getting better fast.
Quality Gap? Not for Long
Skeptics will say the Asian clones aren't quite there yet—that they hallucinate more, that their context windows are smaller, that they lack the polish of Mythos. That's true today. But the gap is closing at a terrifying pace. AetherMind's next release, due in August, promises to match Mythos on 90% of standard benchmarks. Vajra is already deploying its model in government services.
Meanwhile, Anthropic is stuck. Its export ban remains in place, with no sign of easing. The company has tried to lobby for exceptions, but geopolitical tensions are higher than ever. Every month the ban continues is another month Asian startups iterate, improve, and lock in customers.
What Comes Next
I expect to see a full-blown AI Cold War within two years. Not a shooting war—a war of APIs and model weights. The U.S. will dominate in research breakthroughs; Asia will dominate in deployment volume. And the winner? Probably no one. Fragmentation hurts everyone. But for now, the momentum is shifting east.
“The genie is out of the bottle,” said a former U.S. trade official who asked not to be named. “We tried to contain it, and all we did was hand the bottle to someone else.”
U.S. AI labs may never recover this enormous market. They built the best models, but they couldn't sell them. And in this business, if you're not selling, you're dying.
